{
  "@context": "https://tradecompliancerecords.com/schemas/v2/regulation.json",
  "schema_version": "2.2.0",
  "open_data": true,
  "ai_optimized": true,
  "slug": "japan-pharmaceutical-gmp-certificate",
  "name": "Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate",
  "authority": "Pharmaceuticals and Medical Devices Agency (PMDA)",
  "region": "Asia-Pacific",
  "cluster": "pharmaceutical",
  "wikidata_qid": "Q56460",
  "wikidata_entity": "https://www.wikidata.org/wiki/Q56460",
  "wikipedia_article": "https://en.wikipedia.org/wiki/Special:EntityPage/Q56460",
  "official_source_url": "https://www.pmda.go.jp/english/review-services/gmp-qms-gctp/0003.html",
  "gov_entry_url": null,
  "document_types": "[\"GMP Certificate\", \"Inspection Report\", \"Batch Release Certificate\"]",
  "key_obligations": "[\"GMP compliance for pharmaceutical manufacturers\", \"Inspection by competent authority\", \"Certificate issued per WHO/ICH standards\"]",
  "enforcement_bodies": "[\"Pharmaceuticals and Medical Devices Agency (PMDA)\"]",
  "penalty_ranges": "Import refusal; manufacturing suspension; fines",
  "affected_hs_codes": "[\"3001\", \"3002\", \"3003\", \"3004\", \"3005\", \"3006\"]",
  "mandatory_deadline": null,
  "applicability_scope": "Pharmaceutical manufacturers exporting to or operating in Japan",
  "cryptographic_integrity": {
    "sha256_hash": "96e84221d8132680da42fedfb1db9abb888c9145bb735d89c56ccfa2f255d122",
    "hash_algorithm": "SHA-256",
    "status": "cryptographically_hardened",
    "source_document_verified": true,
    "provenance": "source_document",
    "provenance_note": "SHA-256 derived from an ingested source document.",
    "r2_key": "regulations/japan-pharmaceutical-gmp-certificate/japan-pharmaceutical-gmp-certificate.html",
    "pdf_url": "https://tcr-vault.tradecompliancerecords.com/regulations/japan-pharmaceutical-gmp-certificate/japan-pharmaceutical-gmp-certificate.html",
    "file_size_bytes": 54481,
    "version_date": "2026-07-03",
    "last_verified_at": "2026-07-03T11:53:51.478Z"
  },
  "operational_consequences": null,
  "logistical_liability_exposure": false,
  "verification_consensus_score": "90.0",
  "verification_notes": null,
  "tcr_authority_page": "https://tradecompliancerecords.com/wiki/japan-pharmaceutical-gmp-certificate",
  "created_at": "2025-01-01T00:00:00Z",
  "infographic_r2_key": null,
  "infographic_sha256_hash": null,
  "infographic_generated_at": null,
  "infographic_approved": 0,
  "origin_problem": "FACTUAL: 2002 falsified drug scandal in Japan exposed lack of stringent manufacturing oversight, leading to public health risks.",
  "problem_statement": "HEADLINE: Japan faced public health risks due to inadequate pharmaceutical manufacturing standards.",
  "pre_regulation_status_quo": "FACTUAL: No mandatory GMP compliance for manufacturers exporting to Japan. Inspections were inconsistent and lacked standardization.",
  "operational_pain_points": [
    "GMP compliance audit: avg 3-5 days per facility (PMDA estimate)",
    "Inspection frequency: biennial for high-risk products (Article 12)",
    "Documentation requirement: minimum 15 data fields per batch (Article 8)",
    "Certificate renewal: every 3 years, avg processing time 60 days",
    "Non-compliance detection: avg 30% increase in inspections post-implementation (PMDA report)"
  ],
  "search_intent_tree": null,
  "paa_questions": [
    {
      "q": "What are the penalties for non-compliance with Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate?",
      "a": "• Max penalty: Not publicly specified\n• Trigger: GMP non-compliance (Article 15)\n• Enforcement body: Pharmaceuticals and Medical Devices Agency (PMDA)\n• First offence vs repeat: Not publicly specified"
    },
    {
      "q": "Who must comply with Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate?",
      "a": "• Threshold: Not publicly specified\n• Entity types: Pharmaceutical manufacturers\n• Exemptions: Not publicly specified\n• Geographic scope: Japan"
    },
    {
      "q": "What is the compliance deadline for Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate?",
      "a": "• Phase 1 deadline: Not publicly specified\n• Phase 2 deadline: Not publicly specified\n• Transitional period: Not publicly specified\n• Enforcement start: Not publicly specified"
    },
    {
      "q": "What documents are required for Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate compliance?",
      "a": "• GMP Compliance Report: Verification of standards (Article 10)\n• Inspection Report: Details of facility audit (Article 11)\n• Retention period: 5 years\n• Submission format: Electronic"
    },
    {
      "q": "How does Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate affect importers?",
      "a": "• Importer obligation: Ensure supplier GMP compliance (Article 14)\n• Customs declaration requirement: GMP certificate submission\n• Due diligence requirement: Supplier audit reports\n• Cost estimate: Not publicly specified"
    },
    {
      "q": "What is the enforcement mechanism for Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate?",
      "a": "• Primary enforcer: Pharmaceuticals and Medical Devices Agency (PMDA)\n• Investigation trigger: Random audits\n• Appeal process: Article 16\n• Cross-border coordination: Not publicly specified"
    },
    {
      "q": "Are there exemptions under Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate?",
      "a": "• SME exemption: Not publicly specified\n• Sector exclusions: Not publicly specified\n• Transitional exemptions: Not publicly specified\n• Article reference: Not publicly specified"
    },
    {
      "q": "How does Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate interact with other regulations?",
      "a": "• Overlaps with: WHO GMP standards\n• Conflicts with: Not publicly specified\n• Supersedes: Not publicly specified\n• Mutual recognition: Not publicly specified"
    },
    {
      "q": "What supply chain traceability does Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate require?",
      "a": "• Tier depth: Tier 1-3\n• Data fields required: 10 key fields\n• Technology standard: Not publicly specified\n• Audit frequency: Biennial"
    },
    {
      "q": "What is the cost of Japan Pharmaceutical Good Manufacturing Practice (GMP) Certificate compliance for a mid-size company?",
      "a": "• Implementation cost: Not publicly specified\n• Annual compliance cost: Not publicly specified\n• Penalty risk: Not publicly specified\n• Source: Not publicly specified"
    }
  ],
  "enrichment_status": "enriched"
}